... 56 Coronarydisease on angiography 61 61 Angina pectoris 70 71 Percutaneous coronary intervention 42 41 Coronary- artery bypass grafting 38 40 Percutaneous coronary intervention or coronary- artery ... with coronaryarterydisease who had a better prognosis than those in HOPE In the third trial (the PEACE Trial, the subject of the current report), 8290 patients with stablecoronaryarterydisease ... Trial on Reduction of Cardiac Events with Perindopril in StableCoronaryArteryDisease (EUROPA),16 patients with coronary or other vascular disease or with diabetes and another cardiovascular risk...
... Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronaryartery a Indicates patients who received ... Abbreviations: CABG, coronaryartery bypass graft; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; SAP, stable angina pectoris; USAP, unstable angina pectoris ... reduces the rates of clinical and angiographic restenosis in patients with symptomatic coronaryarterydisease (CAD; 4) Also the safety and efficacy of Paclitaxel-eluting stent (PES; Taxus, Boston...
... Abbreviations: Cx, left circumflex coronary artery; LAD, left anterior descending coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronaryartery a Indicates patients who received ... Abbreviations: CABG, coronaryartery bypass graft; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; SAP, stable angina pectoris; USAP, unstable angina pectoris ... coronaryarterydisease that was treated with either the SES or the PES METHODS Patient Population The study population consisted of 204 consecutive series of all patients who had undergone coronary...
... aspects of coronaryartery function and structure with prevalent genetic factors Gene Polymorphism and Coronary Heart Disease 11 Fig The risk factors contributing to coronaryarterydisease pathways ... 7-like Table Summary of the important risk genes and disease pathways leading to the manifestation of coronaryarterydisease 14 CoronaryArteryDisease – New Insights and Novel Approaches Familial ... acquired and inherited risk factors of this complex disease Genetics and drug therapy of coronaryarterydisease Treatment of coronaryarterydisease entails among others, lowering of circulating...
... of CoronaryArtery Disease" , systemic vasculitis ( "Coronary ArteryDisease and Systemic Vasculitis: Case Report and Review"), professional stress ("Occupational Stress and CoronaryArtery Disease" ), ... from Acute Coronary Syndrome 225 Mohaddeseh Behjati Part CoronaryArteryDisease and Comorbidities 259 Chapter 12 Impact of Thyroid Dysfunction on Natural Course of CoronaryArteryDisease 261 ... Part Chapter Treatment for CoronaryArteryDisease 149 Evaluation of Anti-Ischemic Therapy in CoronaryArtery Disease: A Review 151 Marwan S.M Al-Nimer Chapter 10 Coronary Arterial Drug-Eluting...
... Pathophysiology of CoronaryArteryDisease Chapter Epidemiology of CoronaryArteryDisease John F Beltrame, Rachel Dreyer and Rosanna Tavella Chapter Gender Differences in CoronaryArteryDisease 31 ... epidemiology of coronaryarterydiseaseCoronaryarterydisease (CAD) is the global leading cause of death and may manifest clinically as an acute coronary syndrome such as AMI, or a chronic coronary ... syndromes Coronary atherosclerotic disease involves the epicardial coronary arteries and may manifest as an acute or chronic coronary syndrome Acute coronary syndromes (ACS) typically arise Coronary Artery...
... unstable angina [3] and myocardial infarction [4,5] as well as in patients undergoing percutaneous coronary intervention (PCI) [6,7] Despite the obvious benefits from anti-platelet therapy in coronary ... Exclusion criteria were type diabetes, immunologic or malignant disease, hepatic or kidney disease, heart failure NYHA class III-IV, heart valve disease, thoracal epidural anaesthesia or treatment with ... http://www.translational-medicine.com/content/7/1/42 Effects of platelet inhibiting treatment in coronaryarterydisease When investigating possible effects of platelet-inhibiting treatment with Repeated...
... Patients with coronaryarterydisease (CAD) and refractory or recurrent retrosternal symptoms have a reduction in life expectancy and HRQL compared to patients with stablecoronaryarterydisease [4-7] ... Clopidogrel with or without omeprazole in coronaryarterydisease N Engl J Med 2010, 363:1909-17 43 Juurlink DN: Clopidogrel with or without omeprazole in coronarydisease N Engl J Med 2011, 364:681-2 ... Spertus JA: The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The CoronaryArteryDisease in General Practice (CADENCE) Study Arch Intern Med 2009,...
... autoimmune disease J Exp Med 2004;199:1121-31 Nissen SE, Tuzcu EM, Schoenhagen P, et al Effects of statin therapy on LDL cholesterol, C-reactive protein, and the progression of coronaryarterydisease ... between these two biomarkers and disease progression methods We performed intravascular ultrasonography in 502 patients with angiographically documented coronarydisease Patients were randomly ... both biomarkers that were less than the median (P=0.001) conclusions For patients with coronaryartery disease, the reduced rate of progression of atherosclerosis associated with intensive statin...
... 0.7 0.01 0.10 verity of coronaryarterydisease as having no clinically significant disease, one-, two-, or three-vessel disease, or disease of the left main coronaryartery Patients with three-vessel ... severity of coronarydisease at angiography † The hazard ratio is for three-vessel and left main coronaryarterydisease (CAD) as compared with no clinically significant coronaryarterydisease on ... associated with coronary heart disease. 9,10 However, unlike previous investigators, we used angiographically diagnosed coronaryarterydisease to define existing coronary heart disease Patients...
... a dimensionless quantity [5] In clinical terms strain repre- Tissue Doppler imaging and coronaryarterydisease Smiseth et al 423 sents regional myocardial shortening fraction when measurements ... strain rate are load dependent [5] this is not a major limitation in the assessment of coronaryartery disease, since finding of regional differences is more important than absolute values Methodological ... velocity is the most widely used TDI measure for quantifying regional function in suspected coronaryarterydisease Longitudinal velocity measurements are more reproducible than radial velocities,...
... CABG, coronaryartery bypass surgery; CAD, coronaryartery disease; CI, confidence interval; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction; PTCR, percutaneous transluminal coronary ... of diseased vessels, n (%) CAD, coronaryartery disease; RA, rheumatoid arthritis duration was 17.6 years Approximately 90% of the cases were rheumatoid factor-positive and 53% had nodular disease ... excessive deaths from CV disease [21-25] RA is a heterogeneous disease, and the disease phenotype itself is predictive of mortality; patients with more severe clinical disease have higher mortality...
... and four patients with diffuse coronaryarterydisease underwent coronaryartery bypass grafting (CABG) with adjunctive coronary endarterectomy (CE) of at least one artery in the Department of Thoracic-, ... Extensive endarterectomy of the left anterior descending coronaryartery combined with coronaryartery bypass grafting CoronaryArteryDisease 1995, 6:731-737 Gill IS, Beanlands DS, Boyd WD: Left ... of coronary endarterectomy (CE) [5,6,17-20], it is still used as an adjunctive treatment to coronaryartery bypass grafting (CABG) for patients with highly calcified, end-staged coronary artery...
... with Perindopril in stablecoronaryArterydisease Investigators: Efficacy of perindopril in reduction of cardiovascular events among patients with stablecoronaryartery disease: randomized, ... EURopean trial On Reduction of cardiac events with Perindopril in stablecoronaryArterydisease (EUROPA)[34] and the Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)[35] Although the placebocontrolled ... prevention in patients with coronary disease, they can be easily modified and applied in other communities and for other target conditions Background and rationale Coronaryarterydisease (CAD) leads...
... Patients with coronaryarterydisease (CAD) and refractory or recurrent retrosternal symptoms have a reduction in life expectancy and HRQL compared to patients with stablecoronaryarterydisease [4-7] ... Clopidogrel with or without omeprazole in coronaryarterydisease N Engl J Med 2010, 363:1909-17 43 Juurlink DN: Clopidogrel with or without omeprazole in coronarydisease N Engl J Med 2011, 364:681-2 ... Spertus JA: The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The CoronaryArteryDisease in General Practice (CADENCE) Study Arch Intern Med 2009,...
... prescription include stable angina, coronary bypass grafting, coronary angioplasty, heart failure, atrial fibrillation, cardiac valve disease and surgery, peripheral vascular disease, haemodialysis, ... Antiplatelet Response to Aspirin and Clopidogrel in Patients with CoronaryArteryDisease Undergoing Percutaneous Coronary Intervention by Dr Richard I.S Good B.A., M.B.B.S., M.R.C.P A thesis ... cardiovascular disease 21 1.1.1 Introduction 21 1.1.2 The evolution of aspirin for the treatment of cardiovascular disease 21 1.1.3 Dosage of aspirin in cardiovascular disease...